Trials / Completed
CompletedNCT04303468
Intervention With a GABA Supplement in Prediabetics
The Effects of a GABA Supplement Versus a Placebo on Glucose Tolerance and Blood Pressure in Prediabetics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Wageningen University · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In this double-blind parallel placebo controlled intervention study the effects of 3 times daily 500 mg gamma-aminobutyric acid (GABA) supplementation on glucose tolerance and cardiovascular health will be assessed in prediabetics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | GABA | The dietary supplement GABA will be taken orally 3 times daily, before each main meal |
| OTHER | Placebo | Gelatin capsule containing powdered cellulose |
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2021-09-08
- Completion
- 2021-09-08
- First posted
- 2020-03-11
- Last updated
- 2021-11-16
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04303468. Inclusion in this directory is not an endorsement.